We are monitoring the impact of COVID-19 on In-Vitro Toxicology Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 156
Share on
Share on

Global In-Vitro Toxicology Testing Market Analysis - By Product (Assays, Reagents & Labware, Services), Type (ADME, Dose, & Toxic Substance), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (OMICS Technologies, Cell Culture Technology), Method (Cellular Assays, In-Silico Method), Industry (Cosmetics & Household Products, Pharmaceutical), Region – Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 156
Pages: 180

In-Vitro Toxicology Testing Market Size & Growth (2019 - 2024)

The size of the Global In-Vitro Toxicology Testing Market value is expected to reach USD 35712 Million by 2024 from USD 18418 Million in 2019, growing at a CAGR of 14.16% over the next five years.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of the new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Increasing technological advancements, rising research & development in cell culture, growing demand for in-vitro toxicology tests over the conventional in-vivo tests, increasing awareness towards toxicity testing studies, rising health-consciousness amongst individuals, growing economic status in emerging nations, the existence of favorable regulatory authorities for toxicology testing using the in-vitro tests are driving the growth of in-vitro toxicology testing market.

Synergetic relationships between different stakeholders and an increase in toxicology databases to facilitate the use of in-vitro test methods are regarded to offer essential growth opportunities for the players in the global in-vitro toxicology testing market.

Developing condition-specific makers, tests and increasing demand for IVD products in existing countries provide significant opportunities for the various stakeholders. GEM, which is Growth Engagement Model, aims to create or control the action of working with the clients to establish new opportunities.

However, scarcity of in-vitro models to detect immunostimulation & autoimmunity, lack of predictive ability of in vitro testing over in vivo testing, technological advancements limiting the use & decreasing adoption rate are the major factors that restrain the growth of in-vitro toxicology testing market.

Key happenings in this market in the recent past:

  • On February 20, 2020, Catalent Inc. the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies and consumer health products, announced its wholly-owned subsidiary, Catalent Pharma Solutions. 
  • On March 27, 2018, BioIVT, a leading provider of biospecimens and related services, announced that it had acquired Ascendance Biotechnology, Inc. which was formed in 2015 from the merger of Hepregen Corporation and the ESI BIO products division of BioTime Inc. to develop a multi-national cell-based company. 
  • On December 28, 2016, Ascendance Biotechnology Inc., a leader in the commercialization of In-Vitro cell-based products and stem-related laboratory products, announced the agreement with GE healthcare providing a right to manufacture, market and sell the GE Healthcare Cytivaof human stem cell-derived and heart muscle cells used for evaluating potential cardiotoxicity. 
  • On December 06, 2015, BioTime Inc. regenerative medicine company, and Hepregen Corporation, announced the formation of Ascendance Biotechnology Inc. Ascendance combines Hepregen’s application –directed, cellular micro-patterning drug and chemical screening technologies with BioTime’s ESI BIO research products and proprietary stem cell-based technologies. 
  • On January 31, 2012, Sigma-Aldrich, a leading Life Science and High Technology company, announced that it had completed its acquisition of Bio reliance Holdings Inc., a leading provider of biopharmaceutical testing services, from Avista Capital Partners. 

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Product, Type, Toxicity End points and tests, Method, Technology, Industry, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.)

 

This market research report on Global Waste Sorting Robots Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.

In-Vitro Toxicology Testing Market Analysis – By Product

  • Assays
  • Reagents & Labware
  • Services
  • Growth Hormone Therapy

On the basis of product, the Assays segment is estimated to command the largest share of the global in-vitro toxicology testing market by product in 2018.             

In-Vitro Toxicology Testing Market Analysis – By Type

  • ADME (Absorption, Distribution, Metabolism, and Excretion)
  • Dose
  • Toxic Substance

In-Vitro Toxicology Testing Market Analysis – By Toxicity Endpoints & Tests

  • Systemic Toxicity
  • Dermal Toxicity
  • Carcinogenicity
  • Ocular Toxicity
  • Skin Sensitization & Irritation
  • Genotoxicity
  • Neurotoxicity
  • Organ Toxicity
  • Other Toxicity Endpoints & Tests

On the basis of Toxicity Endpoints & Tests, Systemic toxicity is estimated to command the largest share of the global in-vitro toxicology testing market by toxicity endpoints & tests in 2016. Technology is further segmented into OMICS technologies & cell culture technology.

In-Vitro Toxicology Testing Market Analysis – By Technology

  • OMICS Technologies
  • Cell Culture Technology
  • High-Throughput Technologies
  • Molecular Imaging Technologies 

In-Vitro Toxicology Testing Market Analysis – By Method

  • In-Silico Methods
  • Biochemical Assays
  • Cellular Assays
  • Ex-Vivo Models

On the basis of method, the In-silico method is estimated to command the largest share of the global in-vitro toxicology testing market by the method in 2018.

In-Vitro Toxicology Testing Market Analysis – By Industry

  • Cosmetics and Household Products
  • Diagnostics
  • Pharmaceuticals
  • Food Industry
  • Chemicals

On the basis of industry, the cosmetics & household products industry is estimated to account for the largest market share of the global in-vitro toxicology testing market by industry in 2018.

Regional Analysis:

Europe is estimated to account for the largest share of 32.5% of the global in-vitro toxicology testing market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.10% during the forecast period.

Top companies in the Global In-Vitro Toxicology Testing Market

The key players in global in-vitro toxicology testing market include Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.), among others.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Product
      1. Introduction
      2. Assays
      3. Reagents & Labware
      4. Services Growth Hormone Therapy
    2. Type
      1. Introduction
      2. ADME (Absorption, Distribution, Metabolism, and Excretion)
      3. Dose
      4. Toxic Substance
    3. Toxicity Endpoints & Tests
      1. Introduction
      2. Systemic Toxicity
      3. Dermal Toxicity
      4. Carcinogenicity
      5. Ocular Toxicity
      6. Skin Sensitization & Irritation
      7. Genotoxicity
      8. Neurotoxicity
      9. Organ Toxicity
      10. Other Toxicity Endpoints & Tests
    4. Technology
      1. Introduction
      2. OMICS Technologies
      3. Cell Culture Technology
      4. High-Throughput Technologies
      5. Molecular Imaging Technologies
    5. Method
      1. Introduction
      2. In-Silico Methods
      3. Biochemical Assays
      4. Cellular Assays
      5. Ex-Vivo Models
    6. Industry
      1. Introduction
      2. Cosmetics and Household Products
      3. Diagnostics
      4. Pharmaceuticals
      5. Food Industry
      6. Chemicals
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
    4. Latin America
      1. Introduction
      2. Brazil
      3. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. South Africa
      4. Rest of Middle East & Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Covance, Inc   (A subsidiary of LabCorp) (U S )
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agilent Technologies, Inc  (U S )
    3. Bio-Rad Laboratories, Inc  (U S )
    4. Eurofins Scientific SE (Luxembourg)
    5. General Electric Company (U S )
    6. BioReliance, Inc  (U S )
    7. Charles River Laboratories International, Inc  (U S )
    8. Thermo Fisher Scientific, Inc  (U S )
    9. Catalent (U S )
    10. Cyprotex (U K )
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Please go for the sample to get access to the List of Figures and Tables of the report.

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample